Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies.
Balgos A, Hannawi SA, Chen WL, Abuquta A, Safeldin L, Hassan A, Alamadi A, Tirador L, Jaen AM, Villalobos RE, Mo C, Yue ZJ, Ma Y, Wang QS, Wen RD, Yao Z, Yu JP, Yao WR, Zhang JH, Hong KX, Liu Y, Li JX.
Balgos A, et al. Among authors: yao z.
Expert Rev Vaccines. 2024 Mar 26. doi: 10.1080/14760584.2024.2334423. Online ahead of print.
Expert Rev Vaccines. 2024.
PMID: 38529685